Holen Sie sich die Stockscreener-App
5.59
4.88%
0.26
908 Devices Inc Aktie (MASS) Neueste Nachrichten
908 Devices receives $2M order from the Texas Department of Public Safety for drug detection and mitigation - Police1
908 Devices (NASDAQ:MASS) Receives “Sell (D-)” Rating from Weiss Ratings - Defense World
Market Insights: 908 Devices Inc (MASS)’s Notable Drop of -4.59, Closing at 5.40 - DWinneX
MASS’s Market Whiplash: 157.27% YTD Rise, 24.94% Rise in 30 Days - investchronicle.com
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue - Yahoo Finance
908 Devices Inc. Receives $2 Million Order from the Texas Department of Public Safety for Drug Detection and Mitigation - marketscreener.com
Lobbying Update: $22,500 of 908 DEVICES INC. lobbying was just disclosed - Nasdaq
CRISPR Therapeutics AG (CRSP) Is A Buy According To Analysts - Marketing Sentinel
MASS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
908 Devices Gets $2 Million Order From Texas for Drug Detection Tools - marketscreener.com
908 Devices (MASS) Secures $2M Order from Texas Department of Pu - GuruFocus
908 Devices rises after $2 million order from Texas Department of Public Safety - TradingView
908 Devices (MASS) Secures $2M Order from Texas Department of Public Safety | MASS Stock News - GuruFocus
908 Devices Receives $2M Order From The Texas Department Of Public Safety For Drug Detection And Mitigation - marketscreener.com
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation | MASS Stock News - GuruFocus
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation - Business Wire
908 Devices Inc. - firehouse.com
Stifel maintains Buy on 908 Devices, price target steady at $6 - Investing.com Canada
908 Devices reports 55% revenue jump in Q1 By Investing.com - Investing.com South Africa
908 Devices Announces Preliminary First Quarter 2025 Financial Results - BioSpace
908 Devices expects Q1 revenue below estimates - MSN
908 Devices reports preliminary Q1 revenue $11.5M. consensus $11.9M - TipRanks
908 Devices Announces Preliminary First Quarter 2025 Financial R - GuruFocus
908 Devices Announces Preliminary Q1 2025 Financial Results - marketscreener.com
908 Devices reports 55% revenue jump in Q1 - Investing.com
908 Devices Surges with 55% Growth: Q1 Revenue Hits $11.5M After Strategic Portfolio Shift - Stock Titan
Prudential Financial Inc. Makes New Investment in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Leads These 3 Penny Stocks To Consider - Yahoo Finance
908 Devices (NASDAQ:MASS) Earns Sell (D-) Rating from Weiss Ratings - Defense World
The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logility Supply Chain, Palomar and EZCORP - TradingView
Charles Schwab Investment Management Inc. Has $444,000 Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World
Q1 Earnings Estimate for 908 Devices Issued By William Blair - Defense World
Best Momentum Stocks to Buy for March 13th - Yahoo Finance
908 Devices (MASS) Stock Jumps on Strength of New Order Announcement - Stocks Telegraph
908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01net
908 Devices climbs on $1.7 mln order from Ukraine - TradingView
908 Devices secures $1.7 million order from Ukraine - Investing.com India
908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa
908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com
What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register
908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
Weiss Ratings Reaffirms Sell (E+) Rating for 908 Devices (NASDAQ:MASS) - Defense World
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - MSN
908 Devices Inc. SEC 10-K Report - TradingView
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
908 Devices Makes Key Divestiture (Rating Upgrade) (NASDAQ:MASS) - Seeking Alpha
908 Devices earnings missed by $0.33, revenue fell short of estimates - Investing.com Australia
Stifel maintains Buy on 908 Devices, target steady at $6 By Investing.com - Investing.com Canada
Stifel maintains Buy on 908 Devices, target steady at $6 - Investing.com India
908 Devices Inc. Reports Strategic Transformation and Growth - MSN
Repligen lays down $70m to buy analytics tech from 908 Devices - BioProcess Insider
0.45%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):